HomeAbout

TL;DR CNBC


FDA authorizes Novavax’s updated Covid vaccine, paving way for fall rollout - TL;DR CNBC

FDA authorizes Novavax’s updated Covid vaccine, paving way for fall rollout

Publishing timestamp: 2024-08-30 15:50:23


Summary

The FDA authorized Novavax's protein-based Covid vaccine for emergency use in people ages 12 and up, targeting the omicron subvariant JN.1. The vaccine is expected to compete with Pfizer and Moderna's shots and has shown protection against other variants. Novavax's shares rose more than 8% following the announcement.


Sentiment: POSITIVE

Tickers: PFEMRNANVAX

Keywords: pfizer incbiotech and pharmaceuticalsbusinesshealth care industrynovavax incsciencemoderna incbreaking news: businessbusiness newspharmaceuticalsunited statesbiotechnology

Source: https://www.cnbc.com/2024/08/30/fda-authorizes-novavax-protein-covid-vaccine.html


Developed by Leo Phan